Compare MYFW & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MYFW | SWKH |
|---|---|---|
| Founded | 2002 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.6M | 205.9M |
| IPO Year | 2018 | N/A |
| Metric | MYFW | SWKH |
|---|---|---|
| Price | $25.25 | $16.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $24.25 | $18.00 |
| AVG Volume (30 Days) | ★ 21.4K | 5.5K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $90,071,000.00 | N/A |
| Revenue This Year | $15.96 | $52.93 |
| Revenue Next Year | $12.84 | N/A |
| P/E Ratio | $25.00 | ★ $9.18 |
| Revenue Growth | ★ 8.92 | N/A |
| 52 Week Low | $17.55 | $13.00 |
| 52 Week High | $28.00 | $18.66 |
| Indicator | MYFW | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | N/A |
| Support Level | $22.20 | N/A |
| Resistance Level | $28.00 | N/A |
| Average True Range (ATR) | 0.60 | 0.00 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 24.63 | 0.00 |
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.